{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:47:28Z","timestamp":1793126848562,"version":"4.5.0"},"reference-count":39,"publisher":"Scientific Scholar","content-domain":{"domain":["ruralneuropractice.com"],"crossmark-restriction":true},"short-container-title":["JNRP"],"abstract":"\nObjectives:<\/jats:title>\nThis study reviews the effect of albumin-induced volume expansion therapy on symptomatic vasospasm and clinical outcome in aneurysmal subarachnoid hemorrhage (aSAH).<\/jats:p>\n<\/jats:sec>\n\nMaterials and Methods:<\/jats:title>\nComputer searches carried out from the Scopus, Medline, Embase, Web of Science, the Cochrane Library, and Internet documents; hand searching of medical journals; and review of reference lists. Randomized controlled trials (RCT) and observational studies (OSs) comparing albumin therapy in combination or alone with crystalloid therapy for the treatment of cerebral vasospasm in aSAH were included in the study. Risk-of-bias assessment was conducted using ROB2.0 and ROBINS-I tools for RCTs and Oss, respectively.<\/jats:p>\n<\/jats:sec>\n\nResults:<\/jats:title>\nOut of a total of 1078 searches, one RCT (published in two articles) and one observational (retrospective) study were included for final analysis. In RCT, albumin was used for volume expansion therapy with a baseline crystalloid regime and comparison made between hypervolemic and normovolemic groups and it showed no beneficial effects on symptomatic vasospasm and clinical outcomes based on the Glasgow outcome scale. Furthermore, the use of albumin showed a tendency for sodium retention with lowering of glomerular filtration rate, limiting the amount of total fluid required for targeted central venous pressure values, and thereby avoiding fluid overload manifestations. The retrospective study results between albumin versus non-albumin groups (crystalloids only) supported improved outcomes in the former group with lower in-hospital mortality. Cardiorespiratory complications were equivocal in RCT and increased in non-albumin group in the retrospective study. Risk-of-bias assessment analyses revealed \u201csome concerns\u201d in RCT and \u201cserious\u201d limitation in OS due to its retrospective design.<\/jats:p>\n<\/jats:sec>\n\nConclusion:<\/jats:title>\nAlbumin-induced volume expansion therapy for cerebral vasospasm does not have substantiative evidence to improve cerebral vasospasm and clinical outcomes in aSAH. Studies with well-designed RCTs are required to compare the use of albumin for volume expansion therapy versus standard fluid management using crystalloids to mitigate the scarcity of published data.<\/jats:p>\n<\/jats:sec>","DOI":"10.25259\/jnrp_372_2023","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T08:45:32Z","timestamp":1696841132000},"page":"582-590","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Role of albumin-induced volume expansion therapy for cerebral vasospasm in aneurysmal subarachnoid hemorrhage: A systematic review"],"prefix":"10.25259","volume":"14","author":[{"given":"Arshad","family":"Ali","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Neuroscience Institute, Hamad Medical Corporation, Doha, Qatar,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun Babu","family":"Rajeswaran","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisar","family":"Shaikh","sequence":"additional","affiliation":[{"name":"Surgical Intensive Care Unit, Hamad Medical Corporation, Doha, Qatar,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghaya","family":"Al-Rumaihi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Neuroscience Institute, Hamad Medical Corporation, Doha, Qatar,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanem","family":"Al-Sulaiti","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Neuroscience Institute, Hamad Medical Corporation, Doha, Qatar,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2023,10,3]]},"reference":[{"key":"10.25259\/JNRP_372_2023\/ref-1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0140-6736(16)30668-7","article-title":"Spontaneous subarachnoid haemorrhage","volume":"389","author":"Macdonald","year":"2017","journal-title":"Lancet"},{"key":"10.25259\/JNRP_372_2023\/ref-2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1056\/NEJMra052732","article-title":"Aneurysmal subarachnoid hemorrhage","volume":"354","author":"Suarez","year":"2006","journal-title":"N Engl J Med"},{"key":"10.25259\/JNRP_372_2023\/ref-3","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1136\/jnnp.2007.117655","article-title":"Incidence of subarachnoid haemorrhage: A systematic review with emphasis on region, age, gender and time trends","volume":"78","author":"de Rooij","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.25259\/JNRP_372_2023\/ref-4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3233\/NRE-2012-0737","article-title":"Predictors of long-term health-related quality of life in patients with aneurysmal subarachnoid hemorrhage","volume":"30","author":"Passier","year":"2012","journal-title":"NeuroRehabilitation"},{"key":"10.25259\/JNRP_372_2023\/ref-5","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1161\/01.STR.28.3.660","article-title":"Case-fatality rates and functional outcome after subarachnoid hemorrhage: A systematic review","volume":"28","author":"Hop","year":"1997","journal-title":"Stroke"},{"key":"10.25259\/JNRP_372_2023\/ref-6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3171\/jns.1990.73.1.0018","article-title":"The international cooperative study on the timing of aneurysm surgery: Part 1: Overall management results","volume":"73","author":"Kassell","year":"1990","journal-title":"J Neurosurg"},{"key":"10.25259\/JNRP_372_2023\/ref-7","doi-asserted-by":"publisher","first-page":"CD000277","DOI":"10.1002\/14651858.CD000277.pub3","article-title":"Calcium antagonists for aneurysmal subarachnoid haemorrhage","volume":"2007","author":"Dorhout Mees","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.25259\/JNRP_372_2023\/ref-8","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S1474-4422(10)70087-9","article-title":"Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage","volume":"9","author":"Rabinstein","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.25259\/JNRP_372_2023\/ref-9","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/00006123-198409000-00010","article-title":"Depression of circulating blood volume in patients after subarachnoid hemorrhage: Implications for the management of symptomatic vasospasm","volume":"15","author":"Solomon","year":"1984","journal-title":"Neurosurgery"},{"key":"10.25259\/JNRP_372_2023\/ref-10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1600-0404.1991.tb04687.x","article-title":"Cerebral blood flow and metabolism following subarachnoid haemorrhage: Effect of subarachnoid blood","volume":"83","author":"Jakobsen","year":"1991","journal-title":"Acta Neurol Scand"},{"key":"10.25259\/JNRP_372_2023\/ref-11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1161\/01.STR.0000053848.06436.AB","article-title":"Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage","volume":"34","author":"Borel","year":"2003","journal-title":"Stroke"},{"key":"10.25259\/JNRP_372_2023\/ref-12","doi-asserted-by":"publisher","first-page":"CD000483","DOI":"10.1002\/14651858.CD000483.pub2","article-title":"Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage","volume":"2004","author":"Rinkel","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.25259\/JNRP_372_2023\/ref-13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1161\/01.STR.31.2.383","article-title":"Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: A randomized controlled trial","volume":"31","author":"Lennihan","year":"2000","journal-title":"Stroke"},{"key":"10.25259\/JNRP_372_2023\/ref-14","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/00006123-199804000-00048","article-title":"Effect of 5% albumin solution on sodium balance and blood volume after subarachnoid hemorrhage","volume":"42","author":"Mayer","year":"1998","journal-title":"Neurosurgery"},{"key":"10.25259\/JNRP_372_2023\/ref-15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3171\/jns.2004.100.4.0585","article-title":"Effect of human albumin administration on clinical outcome and hospital cost in patients with subarachnoid hemorrhage","volume":"100","author":"Suarez","year":"2004","journal-title":"J Neurosurg"},{"key":"10.25259\/JNRP_372_2023\/ref-16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0006-8993(98)00674-X","article-title":"The effect of high-dose albumin therapy on local cerebral perfusion after transient focal cerebral ischemia in rats","volume":"804","author":"Huh","year":"1998","journal-title":"Brain Res"},{"key":"10.25259\/JNRP_372_2023\/ref-17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1089\/neu.1999.16.445","article-title":"Posttreatment with high-dose albumin reduces histopathological damage and improves neurological deficit following fluid percussion brain injury in rats","volume":"16","author":"Belayev","year":"1999","journal-title":"J Neurotrauma"},{"key":"10.25259\/JNRP_372_2023\/ref-18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/00006123-199301000-00012","article-title":"The hemodynamic effects of prolonged albumin administration in beagle dogs exposed to experimental subarachnoid hemorrhage","volume":"32","author":"Matsui","year":"1993","journal-title":"Neurosurgery"},{"key":"10.25259\/JNRP_372_2023\/ref-19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12028-010-9392-8","article-title":"Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design","volume":"13","author":"Suarez","year":"2010","journal-title":"Neurocrit Care"},{"key":"10.25259\/JNRP_372_2023\/ref-20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1161\/STROKEAHA.111.633958","article-title":"The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: Safety and neurologic outcomes","volume":"43","author":"Suarez","year":"2012","journal-title":"Stroke"},{"key":"10.25259\/JNRP_372_2023\/ref-21","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Sur"},{"key":"10.25259\/JNRP_372_2023\/ref-22","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.25259\/JNRP_372_2023\/ref-23","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.25259\/JNRP_372_2023\/ref-24","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/00006123-200003000-00001","article-title":"Molecular keys to the problems of cerebral vasospasm","volume":"46","author":"Dietrich","year":"2000","journal-title":"Neurosurgery"},{"key":"10.25259\/JNRP_372_2023\/ref-25","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1097\/00006123-200212000-00018","article-title":"Chronological changes of the contractile mechanism in prolonged vasospasm after subarachnoid hemorrhage: From protein kinase C to protein tyrosine kinase","volume":"51","author":"Koide","year":"2002","journal-title":"Neurosurgery"},{"key":"10.25259\/JNRP_372_2023\/ref-26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1254\/jjp.88.227","article-title":"Cerebrovascular inflammation following subarachnoid hemorrhage","volume":"88","author":"Sercombe","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"10.25259\/JNRP_372_2023\/ref-27","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1227\/00006123-199003000-00013","article-title":"Early aneurysm surgery and preventive therapy with intravenously administered nimodipine: A multicenter, double-blind, dose-comparison study","volume":"26","author":"Gilsbach","year":"1990","journal-title":"Neurosurgery"},{"key":"10.25259\/JNRP_372_2023\/ref-28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1161\/01.STR.18.2.365","article-title":"Clinical vasospasm after subarachnoid hemorrhage: Response to hypervolemic hemodilution and arterial hypertension","volume":"18","author":"Awad","year":"1987","journal-title":"Stroke"},{"key":"10.25259\/JNRP_372_2023\/ref-29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/neurosurgery\/29.CN_suppl_1.40","article-title":"Volume expansion in focal cerebral ischemia: The effect of cardiac output on local cerebral blood flow","volume":"29","author":"Keller","year":"1982","journal-title":"Clin Neurosurg"},{"key":"10.25259\/JNRP_372_2023\/ref-30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0895-4356(97)00015-2","article-title":"Association of serum albumin and mortality risk","volume":"50","author":"Goldwasser","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.25259\/JNRP_372_2023\/ref-31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1136\/bmj.317.7153.235","article-title":"Human albumin administration in critically ill patients: Systematic review of randomised controlled trials","volume":"317","author":"Cochrane Injuries Group Albumin Reviewers","year":"1998","journal-title":"BMJ"},{"key":"10.25259\/JNRP_372_2023\/ref-32","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1056\/NEJMoa040232","article-title":"A comparison of albumin and saline for fluid resuscitation in the intensive care unit","volume":"350","author":"Finfer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.25259\/JNRP_372_2023\/ref-33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.7326\/0003-4819-135-3-200108070-00007","article-title":"Patient survival after human albumin administration: A meta-analysis of randomized, controlled trials","volume":"135","author":"Wilkes","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.25259\/JNRP_372_2023\/ref-34","doi-asserted-by":"publisher","first-page":"F284","DOI":"10.1152\/ajprenal.1992.263.2.F284","article-title":"Filtration dynamics and natriuretic response to volume expansion in humans","volume":"263","author":"Loon","year":"1992","journal-title":"Am J Physiol"},{"key":"10.25259\/JNRP_372_2023\/ref-35","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1161\/01.STR.0000231388.72646.05","article-title":"The ALIAS Pilot Trial: A dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: physiological responses and safety results","volume":"37","author":"Ginsberg","year":"2006","journal-title":"Stroke"},{"key":"10.25259\/JNRP_372_2023\/ref-36","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1161\/01.STR.0000231389.34701.b5","article-title":"The ALIAS Pilot Trial: A dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: Neurologic outcome and efficacy analysis","volume":"37","author":"Palesch","year":"2006","journal-title":"Stroke"},{"key":"10.25259\/JNRP_372_2023\/ref-37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3171\/jns.1992.77.2.0253","article-title":"Loss of cerebral regulation during cardiac output variations in focal cerebral ischemia","volume":"77","author":"Tranmer","year":"1992","journal-title":"J Neurosurg"},{"key":"10.25259\/JNRP_372_2023\/ref-38","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/00005373-199603000-00005","article-title":"Colloid infusions reduce glomerular filtration in resuscitated burn victims","volume":"40","author":"Gore","year":"1996","journal-title":"J Trauma"},{"key":"10.25259\/JNRP_372_2023\/ref-39","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-3-319-04981-6_48","article-title":"Effect of human albumin on TCD vasospasm, DCI, and cerebral infarction in subarachnoid hemorrhage: The ALISAH study","volume":"120","author":"Suarez","year":"2015","journal-title":"Acta Neurochir Suppl"}],"container-title":["Journal of Neurosciences in Rural Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ruralneuropractice.com\/role-of-albumin-induced-volume-expansion-therapy-for-cerebral-vasospasm-in-aneurysmal-subarachnoid-hemorrhage-a-systematic-review\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ruralneuropractice.com\/role-of-albumin-induced-volume-expansion-therapy-for-cerebral-vasospasm-in-aneurysmal-subarachnoid-hemorrhage-a-systematic-review\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T09:08:00Z","timestamp":1699693680000},"score":1,"resource":{"primary":{"URL":"https:\/\/ruralneuropractice.com\/role-of-albumin-induced-volume-expansion-therapy-for-cerebral-vasospasm-in-aneurysmal-subarachnoid-hemorrhage-a-systematic-review\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":39,"alternative-id":["10.25259\/JNRP_372_2023"],"URL":"https:\/\/doi.org\/10.25259\/jnrp_372_2023","relation":{},"ISSN":["0976-3155","0976-3147"],"issn-type":[{"value":"0976-3155","type":"electronic"},{"value":"0976-3147","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,3]]},"article-number":"582"}}